GlassScriptPhysician profile
Christopher Kent Dyke
NPI 1891704409
$2,837.48
in general payments reported to CMS, 2019-2025
16 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2021: $139 · 2022: $519 · 2023: $468 · 2024: $814 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,012.35 | 2021-2025 | Ffrct |
| Cleerly, INC. | $501.81 | 2023-2025 | Cleerly Labs, Cleerly Ischemia |
| Ge Healthcare | $255.78 | 2024-2025 | |
| Inari Medical, INC. | $248.57 | 2022 | |
| Pfizer INC. | $144.73 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.62 | 2024 | Lifevest |
| United Therapeutics Corporation | $124.80 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.38 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $107.42 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $52.74 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $30.83 | 2019 | |
| Impulse Dynamics (USA) INC. | $27.78 | 2022 | |
| Amgen INC. | $24.49 | 2019 | |
| Canon Medical Systems USA, INC. | $19.01 | 2023 | Ct Scanner |
| Novartis Pharmaceuticals Corporation | $17.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dyke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.